CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 71 filers reported holding CHEMOCENTRYX INC in Q1 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $181,000 | +57.4% | 3,502 | -24.8% | 0.00% | – |
| Q2 2022 | $115,000 | -81.7% | 4,659 | -81.4% | 0.00% | – |
| Q1 2022 | $629,000 | -77.6% | 25,087 | -67.4% | 0.00% | -100.0% |
| Q4 2021 | $2,805,000 | -54.5% | 77,045 | -78.6% | 0.00% | 0.0% |
| Q3 2021 | $6,165,000 | +247.1% | 360,569 | +171.7% | 0.00% | – |
| Q2 2021 | $1,776,000 | -87.0% | 132,685 | -50.3% | 0.00% | -100.0% |
| Q1 2021 | $13,675,000 | -14.4% | 266,872 | +3.4% | 0.00% | -25.0% |
| Q4 2020 | $15,984,000 | +13.7% | 258,135 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $14,059,000 | +77.1% | 256,529 | +86.0% | 0.00% | +100.0% |
| Q2 2020 | $7,938,000 | +462.6% | 137,952 | +292.9% | 0.00% | – |
| Q1 2020 | $1,411,000 | +73.3% | 35,109 | +70.5% | 0.00% | – |
| Q4 2019 | $814,000 | +48.0% | 20,588 | -74.6% | 0.00% | – |
| Q3 2019 | $550,000 | +0.7% | 81,045 | +38.2% | 0.00% | – |
| Q2 2019 | $546,000 | -69.1% | 58,659 | -53.9% | 0.00% | -100.0% |
| Q1 2019 | $1,765,000 | +139.5% | 127,125 | +88.2% | 0.00% | – |
| Q4 2018 | $737,000 | +21.0% | 67,539 | +40.2% | 0.00% | – |
| Q3 2018 | $609,000 | +0.5% | 48,163 | +4.7% | 0.00% | – |
| Q2 2018 | $606,000 | -15.8% | 46,002 | -13.2% | 0.00% | – |
| Q1 2018 | $720,000 | +148.3% | 52,971 | +8.9% | 0.00% | – |
| Q4 2017 | $290,000 | +13.7% | 48,636 | +41.0% | 0.00% | – |
| Q3 2017 | $255,000 | +15.4% | 34,503 | +46.2% | 0.00% | – |
| Q2 2017 | $221,000 | +32.3% | 23,595 | +3.2% | 0.00% | – |
| Q1 2017 | $167,000 | -17.7% | 22,866 | -16.8% | 0.00% | – |
| Q4 2016 | $203,000 | +136.0% | 27,487 | +93.3% | 0.00% | – |
| Q3 2016 | $86,000 | +8.9% | 14,220 | -18.8% | 0.00% | – |
| Q2 2016 | $79,000 | +97.5% | 17,512 | +10.0% | 0.00% | – |
| Q1 2016 | $40,000 | -67.5% | 15,926 | +4.8% | 0.00% | – |
| Q4 2015 | $123,000 | +28.1% | 15,196 | -4.1% | 0.00% | – |
| Q3 2015 | $96,000 | -23.8% | 15,852 | +3.5% | 0.00% | – |
| Q2 2015 | $126,000 | +472.7% | 15,320 | +414.8% | 0.00% | – |
| Q1 2015 | $22,000 | +144.4% | 2,976 | +134.5% | 0.00% | – |
| Q4 2014 | $9,000 | +50.0% | 1,269 | +0.8% | 0.00% | – |
| Q3 2014 | $6,000 | -45.5% | 1,259 | -35.3% | 0.00% | – |
| Q2 2014 | $11,000 | – | 1,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |